Smart oxygen device could help preterm babies breathe easier

NCT ID NCT07622563

Recruiting now Disease control Sponsor: King's College Hospital NHS Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests a closed-loop automated oxygen control device in 76 preterm infants born before 34 weeks who need breathing support. The device automatically adjusts oxygen levels to keep them in a safe range, aiming to reduce the time babies need extra oxygen and lower the risk of lung problems. Researchers will compare outcomes with standard manual oxygen adjustments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OxyGenie closed-loop automated oxygen control device
What this could lead to: If successful, this device could help preterm infants spend more time with safe oxygen levels, potentially reducing lung damage and time on breathing support.
What could go wrong: This is a small, early-stage trial with only 76 infants, so results may not apply widely. The device may not outperform manual control, and technical issues could arise.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIRWAY MORBIDITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AIRWAY MORBIDITY INFANT PREMATURE

Contacts and locations

Locations

King's College Hospital NHS Foundation Trust
RECRUITING

London, SE5 9RS, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.